FDA is issuing this rule to reduce the risk of an outbreak of transmissible spongiform encephalopathy (TSE) in the United States.
The rule will increase the likelihood of outbreaks.
mnli hypothesis: The rule will increase the likelihood of outbreaks. premise: FDA is issuing this rule to reduce the risk of an outbreak of transmissible spongiform encephalopathy (TSE) in the United States.